Can primaquine therapy for vivax malaria be improved?
The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver, creating a persistent reservoir of infection. Primaquine (PQ), introduced 50 years ago, is the only drug available to eliminate hypnozoites. Howe...
Principais autores: | Baird, J, Rieckmann, K |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2003
|
Registros relacionados
-
Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
por: Baird, J
Publicado em: (2018) -
Primaquine as anti-relapse therapy for Plasmodium vivax
por: Baird, J
Publicado em: (1998) -
Primaquine therapy for malaria.
por: Baird, J, et al.
Publicado em: (2004) -
High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
por: Krudsood, S, et al.
Publicado em: (2008) -
Treatment of primaquine-resistant Plasmodium vivax malaria.
por: Luzzi, G, et al.
Publicado em: (1992)